Accrol Gp Regulatory News (ACRL)

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

22 January 2018

Accrol Group Holdings plc("Accrol" or the "Company")Board Change

Accrol Group Holdings plc (AIM:ACRL) announces that James Flude has resigned as a director of Accrol with effect from 9 February 2018 and will leave the Company on that date to pursue other interests. In the intervening period, James will no longer be the Chief Financial Officer but will remain on the Board as an Executive Director.

The Board has commenced a search for a permanent replacement Chief Financial Officer. In the meantime, Martin Leitch will assume the role of interim Chief Financial Officer but will remain on the operational board.

Gareth Jenkins, Chief Executive Officer of Accrol, commented: "On behalf of the Board, I would like to thank James for the contribution that he has made to Accrol, in particular for his contribution under Private Equity ownership and, more recently, for the key role he played in the successful IPO. We wish him well for the future."

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest wholesalers and retailers.

Accrol operates from three sites:

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

In addition, the business has a storage and distribution facility in Skelmersdale, Lancashire.